2015 Fast Congress Banner  

Cambridge Healthtech Institute’s 3rd Annual  

Phenotypic Drug Discovery 

Maximizing Information in Early Drug Discovery for Better Target and Drug Selection

   November 9-10, 2015 | Renaissance Waterfront Hotel | Boston, MA
 

Phenotypic screening (A.K.A. classical pharmacology) has been historically used in drug discovery. While technological developments have made the prevalence of target-based screening more popular, statistical analysis shows that a disproportionate number of first-in-class drugs with novel mechanisms of action come from phenotypic screening. Cambridge Healthtech Institute’s 3rd Annual Phenotypic Drug Discovery meeting will address the advantages of phenotypic screening vs. target-based screening, and focus on assay development, selection of physiologically relevant models, and subsequent target identification and validation.

Topics include:

  • Assay development
  • Target and pathway identification and validation
  • Physiologically relevant models for phenotypic screening
  • Data analysis for phenotypic screening
  • High-content analysis
  • Chemical genomics, chemical proteomics
  • Quantitative systems pharmacology

The deadline for priority consideration is Friday, May 29, 2015.
Please click here to submit your proposal.

For questions or suggestions about the meeting, please contact:
 
Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute (CHI)
E-mail: juliab@healthtech.com

For sponsorship and exhibit sales information, please contact:
Katelin Fitzgerald
Senior Business Development Manager
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781-972-5458
Email: kfitzgerald@healthtech.com 

For media and association partnerships, please contact:
Jaime Hodges
Marketing Manager
Cambridge Healthtech Institute (CHI)
Phone (+1) 781-972-5429
Email: jhodges@healhtech.com